As part of its plan to promote its anti-cholesterol drug Vytorin, Merck and Schering-Plough paid 16 physicians, 14 of whom hold academic appointments, more than $450,000 for consulting and giving talks, reports the Chronicle of Higher Education. In this article, the Chronicle lists the physicians and the money they received.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.